Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis

Soon Kyu Lee, Myeong Jun Song, Seok Hwan Kim, Hyo Jun Ahn

Clin Mol Hepatol. 2018;24(4):409-416. Published online August 27, 2018

DOI: https://doi.org/10.3350/cmh.2018.0034

View: 11637 Download: 246 Web of Science: 16 Crossref: 17

Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study

Young Min Kim, Suk Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae, Myeong Jun Song, Ji Woong Jang, Soon Young Ko, Jae Dong Lee

Clin Mol Hepatol. 2018;24(3):311-318. Published online June 4, 2018

DOI: https://doi.org/10.3350/cmh.2017.0070

View: 7593 Download: 197 Web of Science: 11 Crossref: 11

A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function

Hyun Yang, Hyun Young Woo, Soon Kyu Lee, Ji Won Han, Bohyun Jang, Hee Chul Nam, Hae Lim Lee, Sung Won Lee, Do Seon Song, Myeong Jun Song, Jung Suk Oh, Ho Jong Chun, Jeong Won Jang, Angelo Lozada, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon

Clin Mol Hepatol. 2017;23(2):128-137. Published online May 10, 2017

DOI: https://doi.org/10.3350/cmh.2016.0071

View: 11522 Download: 190 Web of Science: 24 Crossref: 21

Case Report

Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban

Hyeyoung Yang, Seo Ree Kim, Myeong Jun Song

Clin Mol Hepatol. 2016;22(4):499-502. Published online November 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0016

View: 10899 Download: 230 Web of Science: 25 Crossref: 23

Original Article

Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection

Hee Chul Nam, Hae Lim Lee, Hyun Yang, Myeong Jun Song

Clin Mol Hepatol. 2016;22(2):259-266. Published online June 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0020

View: 9410 Download: 164 Web of Science: 8 Crossref: 7

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease

Young Seok Kim, Eun Sun Jung, Wonhee Hur, Si Hyun Bae, Jong Young Choi, Myeong Jun Song, Chang Wook Kim, Se Hyun Jo, Chang Don Lee, Young Sok Lee, Sang Wook Choi, Jin Mo Yang, Jeong Won Jang, Sang Gyune Kim, Seung Won Jung, Hee Kyung Kim, Hee Bok Chae, Seung Kew Yoon

Clin Mol Hepatol. 2013;19(2):120-130. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.120

View: 10618 Download: 89 Crossref: 24

Differences in the patterns and outcomes of enhanced viral replication between hepatitis C virus and hepatitis B virus in patients with hepatocellular carcinoma during transarterial chemolipiodolization

Pil Soo Sung, Si Hyun Bae, Jeong Won Jang, Do Seon Song, Hee Yeon Kim, Sun Hong Yoo, Chung-Hwa Park, Jung Hyun Kwon, Myeong Jun Song, Chan Ran You, Jong Young Choi, Seung Kew Yoon

Clin Mol Hepatol. 2011;17(4):299-306. Published online December 26, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.4.299

View: 6013 Download: 46 Crossref: 10

1 |

Viewed By 5869	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5212	MAFLD: How is it different from NAFLD?
Viewed By 4934	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4021	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4003	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Cited By 137	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 104	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 82	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 71	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 63	MAFLD: How is it different from NAFLD?

Search